六库尔库通过向c-Srcc来抑制骨质疏松症中的骨质细胞生成和骨破坏
Lihong Li1, Wenqi Dai1, Zhuwei Zhong2
1Laboratory of Anti-inflammatory and Immunomodulatory Pharmacology, Innovation Program of Drug Research on Inflammatory and Immune Diseases, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|February 5, 2026
概括
六基库明 (HHC) 通过抑制骨质细胞的形成和功能来减少骨质疏松症的骨质损失. 这种化合物向c-Src酸化,为骨质疏松症提供了潜在的新疗法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 骨生物学 骨生物学 骨生物学
- 自然产品 自然产品
背景情况:
- 骨质疏松症的特点是骨损失和脆弱性.
- 向骨质细胞生成是一种关键的治疗方法.
- 六基库明 (HHC) 有抗炎和抗氧化作用,但其在骨质疏松症中的作用尚不清楚.
研究的目的:
- 在体内研究HHC对骨质细胞分化和骨质疏松症的影响.
- 探索HHC对骨质细胞的作用背后的分子机制.
主要方法:
- 使用RANKL诱导的骨质细胞前体的体外研究.
- 使用卵巢切除 (OVX) 诱导的骨质疏松性小鼠模型进行体内研究.
- 对c-Src酸化,Ca2+流入,NFATc1转位和骨质结晶性基因表达 (Acp5,Mmp9) 的分析.
- 通过siRNA介导的c-Src沉默来验证该机制.
主要成果:
- 在实验室中,HHC显著降低了骨质细胞的产生和骨的再吸收.
- HHC抑制了c-Src酸化,Ca2+的流入,以及NFATc1的核转位.
- HHC抑制了Acp5和Mmp9的表达.
- 在OVX诱导的骨质疏松症小鼠中,HHC减轻了骨质损失.
结论:
- HHC通过向c-Src来抑制骨质细胞形成,从而减轻骨质疏松症.
- 这些发现表明HHC是骨质疏松症治疗的潜在治疗剂.
相关概念视频
Feedback Inhibition
57.2K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.2K
Non-destructive Tests for Concrete Strength
557
The rebound hammer test, also known as the Schmidt hammer test, is a non-destructive technique for evaluating the hardness of concrete and, indirectly, the strength of concrete. It operates on the principle that the rebound of a spring-driven mass from a concrete surface correlates to the surface's hardness. The device comprises a mass within a tubular housing, a spring mechanism, and a plunger that strikes the concrete. Upon release, the energy imparted to the mass by the spring causes it...
557
Enzyme Inhibition
92.6K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.6K
Inhibition of Cdk Activity
6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Bone Structure
51.8K
Within the skeletal system, the structure of a bone, or osseous tissue, can be exemplified in a long bone, like the femur, where there are two types of osseous tissue: cortical and cancellous.
51.8K
Bone Remodeling
40.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.5K


